Skip Navigation LinksHome > May 2014 - Volume 34 - Issue 5 > AUTOIMMUNE RETINOPATHY AND ANTIRETINAL ANTIBODIES: A REVIEW
Text sizing:
doi: 10.1097/01.iae.0000450880.26367.4e
Corrected and Republished Article


Grewal, Dilraj S. MD*; Fishman, Gerald A. MD; Jampol, Lee M. MD*

Collapse Box


Purpose: To review the current state for diagnosis and management of autoimmune retinopathy.

Methods: A review of the literature was performed, encompassing autoimmune retinopathy including paraneoplastic retinopathy (cancer-associated retinopathy, melanoma-associated retinopathy, and bilateral diffuse uveal melanocytic proliferation) and non-paraneoplastic autoimmune retinopathy. Based on this review, current principles and techniques for diagnosis and the treatments reported for autoimmune retinopathy are discussed with the aim to clarify some of the confusion that exists regarding this complex entity.

Results: Autoimmune retinopathy encompasses a spectrum of retinal degeneration phenotypes. The clinical features, fundus characteristics, and electroretinogram findings for paraneoplastic and non-paraneoplastic retinopathy are reviewed. The different antiretinal antibodies reported in these entities are described. The diagnostic approaches for detecting these antiretinal antibodies and their limitations are covered. The treatments reported for autoimmune retinopathy and their outcomes are reviewed.

Conclusion: Among the myriad of antiretinal antibodies reported, challenges persist in determining which antibodies are pathogenic and which are benign and what factors cause antiretinal antibodies to become pathologic. There also remain difficulties in the detection and accurate measurement of antiretinal antibodies, and the response to therapeutic intervention in autoimmune retinopathy is variable.

© 2014 by Ophthalmic Communications Society, Inc.


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.